Cohort

Performance parameters

Number of cancer

samples

Number of control samples

Specificity

%

Sensitivity

%

Cancer rate

%

DLRp

Optimisation

235

266

90.6

(87.1 - 94.1)

41.3

(35.0 - 47.6)

-

4.4

(2.9 - 6.6)

Audit

19

817

90.5

(88.4 - 92.5)

47.4

(24.9 - 69.8)

2.3

5.0

(3.0 - 8.3)

Nodulec

(4 - 20 mm)

15

87

83.9

(76.2 - 91.6)

40.0

(15.2-64.8)

14.7

2.5

(1.1 - 5.4)

Nodulec

(>20 mm)

22

24

91.7

(80.6 - 100)

36.4

(16.3 - 56.5)

47.8

4.4

(1.0 - 18.4)

Nodule

37

111

85.6

(79.1 - 92.1)

37.8

(22.2 - 53.5)

22.3

2.6

(1.4 - 4.8)